Drug Combo Fails to Improve Mesothelioma Survival
Adding the VEGF-inhibitor bevacizumab to a popular chemotherapy combination for mesothelioma does not appear to prolong survival after all. Scientists at 11…
-
-
Orphan Drug Shows Survival Advantage in Mesothelioma
Long-term follow-up on a second-line drug for mesothelioma confirms its potential for prolonging survival. NGR-hTNF is a vascular targeting agent that… -
New Molecule May Aid Mesothelioma Diagnosis
Scientists at one of the nation’s top cancer centers say they have come up with a new imaging tool that… -
States Wrestle with Legal Side of Mesothelioma
Recent changes in the way some states handle mesothelioma lawsuits may eventually have an impact nationwide. In Pennsylvania, the state Supreme Court… -
Landlord’s Action Puts Tenants at Mesothelioma Risk
Property owners who want to remove asbestos are being urged to heed a lesson learned the hard way by a… -
Unions Call for Asbestos-Free Australia
The head of an Australian Consortium of Trade Unions (ACTU) is calling on the government to protect its citizens against… -
Mesothelioma Risk Depends on Asbestos Fiber Size
Scientists who study the connection between asbestos fibers and mesothelioma say they now understand what size particles pose the most danger.… -
Alaska Lawmakers Allow Asbestos in Gravel
Alaska lawmakers have decided not to let the threat of mesothelioma stand in the way of progress. In April, the state legislature… -
Finding the Mesothelioma Asbestos Connection
Even though the cause of mesothelioma – exposure to asbestos – is well-known, it is not always easy for a mesothelioma patient… -
Effectiveness of Mesothelioma Drug Improved by Other Compounds
Two new studies suggest that a popular mesothelioma drug becomes more effective when combined with other compounds. Pemetrexed (Alimta) is considered…
